|
市場調査レポート
商品コード
1494326
欧州のELISA診断検査：2030年市場予測-地域別分析：導入、検査タイプ、用途、エンドユーザー別Europe ELISA Diagnostics Tests Market Forecast to 2030 - Regional Analysis - by Adoption, Test Type, Application, and End User |
||||||
|
|
|||||||
|
|||||||
| 欧州のELISA診断検査：2030年市場予測-地域別分析：導入、検査タイプ、用途、エンドユーザー別 |
|
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 110 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
欧州のELISA診断検査市場は、2022年に3億1,959万米ドルと評価され、2030年には5億3,465万米ドルに達すると予測され、2022～2030年のCAGRは6.6%で成長すると予測されています。
ヒト感染症の増加が欧州ELISA診断検査市場を活性化
WHOレポート2020によると、非感染性疾患と慢性疾患が世界の成人死亡の大半を占めています。今後10年間で、この数は17％増加すると予想されています。世界のおよそ3人に1人が複数の慢性疾患を抱えています。さらに、非伝染性疾患による年間死亡者数は世界で4,100万人、死亡者数全体の74％を占めています。さらに、毎年1,700万人が70歳になる前にNCDsが原因で死亡しており、中低所得国がこの早期死亡者の86％を占めています。NCDsによる死亡者数は毎年1,790万人であり、心血管系疾患が死亡率の大半を占めています。がん、慢性呼吸器疾患、糖尿病がそれに続きます。ヒトでは、ELISA検査はがん、感染症、自己免疫、内分泌診断、免疫学＆サイトカイン、細胞接着分子（CAM）などを検出するバイオマーカーとして使用されています。ELISA検査は、診断プロセスの初期段階でがんを検出するのに役立ち、患者の生存と適切な治療を受けるためのより良い機会を記載しています。そのため、ELISA検査に対する需要は世界中で高く、予測期間中の市場成長をもたらしています。
欧州ELISA診断検査市場概要
Journal of Thoracic Oncology誌の報告によると、肺がんはドイツにおいて重大な罹患率、死亡率、社会経済的コストを引き起こす原因となっています。男性では、肺がんは心血管疾患に次いで第2位で、2020年の全死因死亡の6.5%を占める。年齢標準化罹患率は男性で32.7、女性で52.1（10万人当たり）であり、肺がんはドイツでは女性で第3位、男性で第2位です。したがって、同国における肺がん有病率の上昇に伴い、ドイツの医療システムにおける肺がん検診と診断の実施が最も重要です。ドイツにおける肺がんの有病率をコントロールするために、市場参入企業はELISA診断検査の製造に注力しています。QIAGEN N.V.もその一つです。2021年5月、QIAGEN N.V.は、非小細胞肺がん（NSCLC）患者を同定するための"therascreen KRAS RGQ PCR Kit "のFDA承認コンパニオン診断（CDx）クレーム第1号の発売を発表しました。Therascreen KRASキットは、NSCLC腫瘍組織サンプル中のKRAS G12C変異を同定するコンパニオン診断検査として、米国食品医薬品局（USFDA）から市販前承認を取得した最初の検査です。したがって、ドイツにおけるがん、特に肺がんの有病率の上昇と、メーカーによる革新的な製品の発売が、ドイツにおけるELISA診断検査市場の成長を後押ししています。
欧州ELISA診断検査市場の収益と2030年までの予測（金額）
欧州ELISA診断検査市場のセグメンテーション
欧州のELISA診断検査市場は、導入、検査タイプ、用途、エンドユーザー、国によって区分されます。採用に基づいて、欧州ELISA診断検査市場はヒトと獣医に二分されます。2022年の市場シェアはヒト用が大きいです。
検査タイプ別では、欧州ELISA診断検査市場はサンドイッチELISA、間接ELISA、競合ELISA、マルチ＆ポータブルELISAに区分されます。間接ELISAセグメントが2022年に最大の市場シェアを占めました。
用途別では、欧州ELISA診断検査市場は自己免疫疾患、感染症、がん診断、タンパク質定量、その他に区分されます。感染症セグメントが2022年に最大の市場シェアを占めました。
エンドユーザー別では、欧州ELISA診断検査市場は、病院・診断センター、製薬・バイオテクノロジー企業、動物病院・診断ラボ、その他に区分されます。病院＆診断センターセグメントが2022年に最大の市場シェアを占めました。
国別では、欧州ELISA診断検査市場はドイツ、英国、フランス、イタリア、スペイン、その他の欧州に区分されます。2022年の欧州ELISA診断検査市場シェアはドイツが独占しました。
Bio-Rad Laboratories Inc.、Idexx Laboratories Inc.、F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Danaher Corp.、Innovative Diagnostics SAS、DiaSorin SpA、Elabscience Biotechnology Inc.、Bio-Techne Corp.は、欧州ELISA診断検査市場で事業を展開している主要企業の一部です。
目次
第1章 イントロダクション
第2章 エグゼクティブ概要
- 主要な洞察
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 欧州ELISA診断検査市場-主要産業力学
- 市場促進要因
- 動物における感染症の増加
- ヒトの感染症発生率の増加
- 主要市場抑制要因
- 製品回収の発生
- 主要市場機会
- 革新的な製品の上市
- 今後の動向
- ELISA法における進歩
第5章 ELISA診断検査市場：欧州市場分析
- イントロダクション
- ELISA診断検査市場の売上高、2022～2030年
第6章 欧州ELISA診断検査市場：導入別収益と2030年までの予測
- イントロダクション
- 欧州ELISA診断検査市場2022年・2030年導入別収益シェア（%）
- ヒト
- 動物
第7章 欧州ELISA診断検査市場：検査タイプ別収益と2030年までの予測
- イントロダクション
- 欧州ELISA診断検査市場：2022年・2030年検査タイプ別売上高シェア（%）
- サンドイッチELISA
- 間接ELISA
- 競合ELISA
- マルチプル＆ポータブルELISA
第8章 欧州ELISA診断検査市場：用途別収益と2030年までの予測
- イントロダクション
- 欧州ELISA診断検査市場：2022年・2030年用途別売上高シェア（%）
- 自己免疫疾患
- 感染症
- がん診断
- タンパク質定量
- その他
第9章 欧州ELISA診断検査市場：エンドユーザー別収益と2030年までの予測
- イントロダクション
- 欧州ELISA診断検査市場：2022年・2030年エンドユーザー別売上高シェア（%）
- 病院・診断センター
- 製薬・バイオテクノロジー企業
- 動物病院・診断ラボ
- その他
第10章 欧州ELISA診断検査市場：2030年までの収益と予測：国別分析
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他の欧州
第11章 ELISA診断検査市場-業界情勢
- イントロダクション
- ELISA診断検査市場の成長戦略
- 有機的成長戦略
- 無機的成長戦略
第12章 企業プロファイル
- Bio-Rad Laboratories Inc
- Idexx Laboratories Inc
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- Danaher Corp
- Innovative Diagnostics SAS
- DiaSorin SpA
- Elabscience Biotechnology Inc
- Bio-Techne Corp
第13章 付録
List Of Tables
- Table 1. ELISA Diagnostic Test Market Segmentation
- Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
- Table 3. Germany ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
- Table 4. Germany ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
- Table 5. Germany ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- Table 6. Germany ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
- Table 7. France ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
- Table 8. France ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
- Table 9. France ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- Table 10. France ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
- Table 11. UK ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
- Table 12. UK ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
- Table 13. UK ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- Table 14. UK ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
- Table 15. Italy ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
- Table 16. Italy ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
- Table 17. Italy ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- Table 18. Italy ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
- Table 19. Spain ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
- Table 20. Spain ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
- Table 21. Spain ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- Table 22. Spain ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
- Table 23. Rest of Europe ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
- Table 24. Rest of Europe ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
- Table 25. Rest of Europe ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- Table 26. Rest of Europe ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
- Table 27. Recent Organic Growth Strategies in ELISA diagnostics Test Market
- Table 28. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
- Table 29. Glossary of Terms, ELISA Diagnostic Tests Market
List Of Figures
- Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
- Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
- Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
- Figure 4. ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
- Figure 5. Europe ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
- Figure 6. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 7. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 8. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
- Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 13. Europe ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
- Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 15. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 17. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 18. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 19. Europe ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
- Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 23. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 24. Europe: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
- Figure 25. Europe: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
- Figure 26. Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 27. France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 28. UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 29. Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 30. Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 31. Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 32. Growth Strategies in ELISA diagnostics test Market
The Europe ELISA diagnostics tests market was valued at US$ 319.59 million in 2022 and is expected to reach US$ 534.65 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.
Increasing Incidence of Human Infections Fuels Europe ELISA Diagnostics Tests Market
According to the WHO Report 2020, noncommunicable and chronic diseases cause the majority of adult deaths worldwide. Over the next ten years, this number is expected to rise by 17%. Roughly one in three persons worldwide deal with several chronic illnesses. Moreover, noncommunicable illnesses account for 41 million annual deaths worldwide, or 74% of all fatalities. Further, 17 million individuals die from NCDs before they become 70 years old every year; low- and middle-income nations account for 86% of these premature fatalities. With 17.9 million fatalities from NCDs each year, cardiovascular illnesses account for the majority of mortality. Cancer, chronic respiratory diseases, and diabetes follow closely behind. In humans, ELISA test is used as a biomarker to detect cancer, infectious diseases, autoimmunity, endocrinology diagnosis, immunology & cytokines, cell adhesion molecules (CAMs), and others. ELISA testing helps detect cancer at the early stage of diagnostic processes, offering a better chance for patient survival and getting appropriate treatment initially. Therefore, demand for ELISA testing is high across the world owing resulting in market growth during the forecast period.
Europe ELISA Diagnostics Tests Market Overview
According to the Journal of Thoracic Oncology report, lung cancer is responsible to cause significant morbidity, mortality, and socioeconomic cost in Germany. In men, lung cancer ranks second after cardiovascular disease, accounting for 6.5% of all-cause mortality in 2020. With an age-standardized incidence rate of 32.7 and 52.1 (per 100,000) in men and women, respectively, lung cancer ranked third in women and second in men in Germany. Therefore, with the rising prevalence of lung cancer in the country, the implementation of lung cancer screening and diagnosis in the German healthcare system is of utmost importance. To control the prevalence of lung cancer in Germany, market players focus on manufacturing ELISA diagnostic tests. QIAGEN N.V. is one such example. In May 2021, QIAGEN N.V. announced the launch of its first FDA-approved companion diagnostic (CDx) claims for the "therascreen KRAS RGQ PCR Kit" to identify non-small cell lung cancer (NSCLC) patients. The therascreen KRAS kit is the first companion diagnostic test to obtain premarket approval from the US Food and Drug Administration (USFDA) to identify the KRAS G12C mutation in samples of NSCLC tumor tissues. Therefore, the rising cancer prevalence, particularly lung cancer in Germany, and innovative product launches by the manufacturers boost the ELISA diagnostic test market growth in Germany.
Europe ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)
Europe ELISA Diagnostics Tests Market Segmentation
The Europe ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Europe ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.
In terms of test type, the Europe ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.
Based on application, the Europe ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.
By end user, the Europe ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.
Based on country, the Europe ELISA diagnostics tests market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe ELISA diagnostics tests market share in 2022.
Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Innovative Diagnostics SAS, DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the Europe ELISA diagnostics tests market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
- 1.2.1 Europe ELISA Diagnostic Tests Market - by Adoption
- 1.2.2 Europe ELISA Diagnostic Tests Market - by Test Type
- 1.2.3 Europe ELISA Diagnostic Tests Market - by Application
- 1.2.4 Europe ELISA Diagnostic Tests Market - by End User
- 1.2.5 Europe ELISA Diagnostic Tests Market - by Country
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe ELISA Diagnostic Test Market - Key Industry Dynamics
- 4.1 Key Market Drivers
- 4.1.1 Rising Infectious Diseases Among Animals
- 4.1.2 Increasing Incidence of Human Infections
- 4.2 Key Market Restraints
- 4.2.1 Incidents of Product Recalls
- 4.3 Key Market Opportunities
- 4.3.1 Innovative Product Launches
- 4.4 Future Trends
- 4.4.1 Advancements in ELISA-Based Procedures
5. ELISA Diagnostic Tests Market - Europe Market Analysis
- 5.1 Overview
- 5.2 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030
6. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption
- 6.1 Overview
- 6.2 Europe ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
- 6.3 Human
- 6.3.1 Overview
- 6.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4 Veterinary
- 6.4.1 Overview
- 6.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type
- 7.1 Overview
- 7.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
- 7.3 Sandwich ELISA
- 7.3.1 Overview
- 7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Indirect ELISA
- 7.4.1 Overview
- 7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Competitive ELISA
- 7.5.1 Overview
- 7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6 Multiple & Portable ELISA
- 7.6.1 Overview
- 7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application
- 8.1 Overview
- 8.2 Europe ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
- 8.3 Autoimmune Diseases
- 8.3.1 Overview
- 8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Infectious Disease
- 8.4.1 Overview
- 8.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Cancer Diagnosis
- 8.5.1 Overview
- 8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Protein Quantification
- 8.6.1 Overview
- 8.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User
- 9.1 Overview
- 9.2 Europe ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
- 9.3 Hospitals & Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Pharmaceutical & Biotechnology Companies
- 9.4.1 Overview
- 9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Veterinary Hospitals & Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Country Analysis
- 10.1 Europe: ELISA Diagnostic Tests Market
- 10.1.1 Europe: ELISA Diagnostic Tests Market, by Country
- 10.1.1.1 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 10.1.1.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 10.1.1.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.3 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 10.1.1.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.4 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Overview
- 10.1.1.4.2 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 10.1.1.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.5 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Overview
- 10.1.1.5.2 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 10.1.1.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.6 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Overview
- 10.1.1.6.2 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
- 10.1.1.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
- 10.1.1.1 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1 Europe: ELISA Diagnostic Tests Market, by Country
11. ELISA Diagnostics Test Market-Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in ELISA diagnostics test Market
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
- 11.4 Inorganic Growth Strategies
- 11.4.1 Overview
12. Company Profiles
- 12.1 Bio-Rad Laboratories Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Idexx Laboratories Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 F. Hoffmann-La Roche Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Thermo Fisher Scientific Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Abbott Laboratories
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Danaher Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Innovative Diagnostics SAS
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 DiaSorin SpA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Elabscience Biotechnology Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Financial Overview
- 12.9.4 SWOT Analysis
- 12.9.5 Key Developments
- 12.10 Bio-Techne Corp
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms
